Change search
ReferencesLink to record
Permanent link

Direct link
Natriuretic Peptides
Umeå University, Faculty of Medicine, Department of Public Health and Clinical Medicine, Cardiology.
2010 (English)In: Heart Failure in Clinical Practice / [ed] Michael Y. Henein, Springer London, 2010, 309-318 p.Chapter in book (Other academic)
Abstract [en]

Natriuretic peptides are clinically used as biomarkers of heart failure and have in recent years become more and more valuable in the diagnosis of heart failure. B-type natriuretic peptide (BNP) and N-terminal pro-BNP (NT-pro-BNP) have become commercially available, their accurate assays have been made, and their most widespread use has been achieved, although other natriuretic peptides can be of interest as well. The body of data supporting the use of BNP and NT-pro-BNP is steadily increasing. Low levels of BNP and NT-pro-BNP can, because of their high negative predictive values, be used to rule out heart failure, and high levels of these peptides predict a poor prognosis. There are, however, several pitfalls in the use of natriuretic peptides that one has to be aware of when using them in routine clinical practice. Many unanswered questions also remain to be resolved

Place, publisher, year, edition, pages
Springer London, 2010. 309-318 p.
National Category
Cardiac and Cardiovascular Systems
URN: urn:nbn:se:umu:diva-75746DOI: 10.1007/978-1-84996-153-0_17ISI: 000284026100017ISBN: 978-1-84996-152-3ISBN: 978-1-84996-153-0OAI: diva2:635444
Available from: 2013-07-04 Created: 2013-07-03 Last updated: 2013-07-04Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Lindmark, Krister
By organisation
Cardiac and Cardiovascular Systems

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 39 hits
ReferencesLink to record
Permanent link

Direct link